A detailed history of Geode Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 8,500,887 shares of TEVA stock, worth $149 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,500,887
Previous 8,102,722 4.91%
Holding current value
$149 Million
Previous $114 Million 20.83%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$12.78 - $17.4 $5.09 Million - $6.93 Million
398,165 Added 4.91%
8,500,887 $138 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $3.45 Million - $4.67 Million
323,737 Added 4.16%
8,102,722 $114 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $2.3 Million - $3.01 Million
283,206 Added 3.78%
7,778,985 $81.2 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $2.61 Million - $3.74 Million
349,180 Added 4.89%
7,495,779 $76.5 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $2.84 Million - $3.73 Million
394,037 Added 5.84%
7,146,599 $53.8 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $1.73 Million - $2.36 Million
207,161 Added 3.16%
6,752,562 $59.8 Million
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $697,318 - $831,519
-87,713 Reduced 1.32%
6,545,401 $59.5 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $2.16 Million - $3.76 Million
314,715 Added 4.98%
6,633,114 $53.4 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $1.7 Million - $2.4 Million
230,504 Added 3.79%
6,318,399 $47.4 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $1.16 Million - $1.49 Million
158,493 Added 2.67%
6,087,895 $57 Million
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $1.64 Million - $2.12 Million
207,724 Added 3.63%
5,929,402 $47.3 Million
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $4.48 Million - $5.44 Million
534,109 Added 10.3%
5,721,678 $55.5 Million
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $4.81 Million - $5.62 Million
486,108 Added 10.34%
5,187,569 $51.2 Million
Q1 2021

May 12, 2021

SELL
$10.34 - $12.81 $2.16 Million - $2.67 Million
-208,644 Reduced 4.25%
4,701,461 $54.1 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $5 Million - $6.41 Million
580,306 Added 13.4%
4,910,105 $47.2 Million
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $64,617 - $95,682
7,540 Added 0.17%
4,329,799 $38.9 Million
Q2 2020

Aug 13, 2020

BUY
$8.12 - $13.12 $296,850 - $479,640
36,558 Added 0.85%
4,322,259 $53.2 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $187,447 - $376,855
28,019 Added 0.66%
4,285,701 $38.4 Million
Q4 2019

Feb 13, 2020

BUY
$6.53 - $10.72 $571,903 - $938,868
87,581 Added 2.1%
4,257,682 $41.6 Million
Q3 2019

Nov 12, 2019

BUY
$6.16 - $9.6 $2.2 Million - $3.43 Million
357,325 Added 9.37%
4,170,101 $28.6 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $4.55 Million - $8.81 Million
560,511 Added 17.23%
3,812,776 $35.1 Million
Q1 2019

May 14, 2019

BUY
$15.58 - $20.01 $1.96 Million - $2.51 Million
125,681 Added 4.02%
3,252,265 $50.9 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $4.07 Million - $6.66 Million
279,286 Added 9.81%
3,126,584 $48.1 Million
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $3.15 Million - $3.84 Million
149,549 Added 5.54%
2,847,298 $61.2 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $3.6 Million - $5.31 Million
214,920 Added 8.66%
2,697,749 $65.5 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $2.85 Million - $3.77 Million
170,611 Added 7.38%
2,482,829 $42.3 Million
Q4 2017

Feb 13, 2018

BUY
$11.23 - $19.1 $1.05 Million - $1.78 Million
93,175 Added 4.2%
2,312,218 $43.7 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $511,319 - $1.07 Million
33,181 Added 1.52%
2,219,043 $39 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,185,862
2,185,862 $72.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.